Skip to Main Content
Our Commitment to Diversity

K&L Gates Advises Axonics on $138 Million IPO

21 November 2018
Orange County - Global law firm K&L Gates LLP has advised medical technology company Axonics Modulation Technologies, Inc. on its successful initial public offering of 9.2 million shares of common stock, raising $138 million in gross proceeds before underwriting discounts, commissions, and offering expenses.
Axonics’ common stock began trading on The Nasdaq Global Select Market under the ticker symbol “AXNX” on October 31, 2018.
The K&L Gates team that advised Axonics was led by Orange County managing partner Michael Hedge. Other key team members from K&L Gates include food, drugs, medical devices and cosmetics partner Michael Hinckle, employee benefits partner Matthew Jones, and corporate associates Jason Dreibelbis, Alexa Ekman, and Hillary O’Rourke.

K&L Gates is a fully integrated global law firm with lawyers located across five continents. The firm represents leading multinational corporations, growth and middle-market companies, capital markets participants and entrepreneurs in every major industry group as well as public sector entities, educational institutions, philanthropic organizations and individuals.

Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel